Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-173736

Director sold 10,952 shares at an average $20.01 ($219,170)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kersten Dirk · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-21 Sale : show line 1 in the form 10b5-1 −8,300 $20.01 $166,120 4,199,225 I
2026-04-22 Sale : show line 2 in the form 10b5-1 −2,652 $20.00 $53,049 4,196,573 I
Open-market sales · 10,952 sh · avg $20.01 · $219,170
Loading xslF345X06/ownership.xml…